Stuart Orkin Wins Brinster Prize for Sickle Cell Gene Therapy Breakthrough

Sickle cell disease affects millions globally, particularly in African and African-American populations, causing severe pain and organ damage; this therapy offers potential relief.

In the long human effort to understand why the body silences certain genes at birth, Stuart Orkin of Harvard Medical School found not only an answer but a doorway — one that opens toward relief for millions living with sickle cell disease. His decades of inquiry into fetal hemoglobin regulation have earned him the Elaine Redding Brinster Prize, a recognition that honors the rare arc from fundamental curiosity to clinical application. The award, carrying $100,000 and a ceremonial lecture at the University of Pennsylvania, affirms that basic science pursued with patience can become medicine purs

Stuart Orkin Wins Brinster Prize for Sickle Cell Gene Therapy Breakthrough

Cobertura Relacionada

Recibe The Register en tu bandeja